Oriental Aromatics Limited has fixed Wednesday, August 5, 2026, as the record date to determine shareholder eligibility for a dividend of ₹0.50 per equity share. The payout, recommended by the Board on May 20, 2026, is subject to approval at the 54th Annual General Meeting scheduled for Tuesday, August 18, 2026. Shareholders whose names appear in the register of members or the list of beneficial owners maintained by depositories on the record date will be entitled to receive the dividend.

The AGM will be held at 11:00 a.m. IST via Video Conferencing (VC) and Other Audio Visual Means (OAVM). In compliance with regulatory provisions, the meeting will be conducted without a physical venue. Members attending through VC/OAVM will be counted for the purpose of quorum under Section 103 of the Companies Act, 2013. The Notice of AGM and the Annual Report for FY26 will be sent electronically to members with registered email addresses, while others will receive a communication containing the web link to access these documents.

The company has provided remote e-voting facilities to all members to cast votes on resolutions set forth in the notice. Detailed procedures for remote e-voting and participation in the AGM through VC/OAVM are outlined in the notice. Members holding shares in physical or dematerialized mode who have not registered their email addresses are requested to update them with the Registrar and Share Transfer Agent, MUFG Intime India Private Limited, or their depository participants respectively.

Key AGM and Dividend Details

Dividend payments will be made electronically to shareholders who have complied with KYC norms. The company has stated that dividend is taxable in the hands of shareholders, and tax deducted at source (TDS) will be applicable as per the provisions of the Income Tax Act, 2025. Members are requested to submit necessary documents such as Form 15G or 15H by August 5, 2026, to facilitate appropriate TDS deduction.

Oriental Aromatics Limited reported a consolidated revenue from operations of INR 1,030.8 crore for the financial year ended March 31, 2026, marking an 11% year-on-year growth. This milestone was achieved despite a challenging external environment characterized by pricing pressure and raw material cost inflation. The Board has recommended a final dividend of INR 0.50 per equity share, subject to shareholder approval at the upcoming Annual General Meeting.

For the fourth quarter of FY26, operating revenue stood at INR 282 crore, reflecting a growth of 12% quarter-on-quarter and 11% year-on-year. EBITDA for the quarter improved to INR 19.5 crore compared to INR 13.2 crore in the previous quarter, with margins expanding to 6.89%. Profit after tax for Q4 FY26 was INR 3.98 crore, recovering from a loss of INR 1.92 crore in the preceding quarter.

Financial Performance

The company's full-year EBITDA declined to INR 68 crore from INR 93.3 crore in FY25, resulting in EBITDA margins of 6.6% compared to 10.06% in the previous year. Profit after tax for FY26 stood at INR 3.3 crore, down from INR 34.3 crore in FY25. The net debt equity ratio as of March 31, 2026, was 0.58x, and the Return on Capital Employed (ROCE) was 4.85%.

Operational Highlights

Total sales volume for Q4 FY26 increased by 16% quarter-on-quarter and 5% year-on-year. For the full year, total sales volume grew by 9% over FY25, while production volume increased by 5%. Management attributed the margin compression to a combination of factors, including pricing pressure in the Aroma Ingredients division, rising raw material costs, currency depreciation, and the drag from the Mahad facility ramp-up.

The Mahad facility, operated by Oriental Aromatics & Sons Limited, continues to be in the ramp-up phase and is currently impacting consolidated EBITDA margins by 1% to 1.5%. Management expects the plant to achieve EBITDA neutrality at a utilization level of 75% to 80% within the next year. The facility is anticipated to add approximately INR 60 crore to INR 65 crore in revenue at optimum utilization.

Outlook

Management noted that input costs, particularly for gum turpentine, CST, and alpha-pinene, are at all-time highs. While the company has implemented price increases of 25% to 27% to mitigate these costs, the buyer's market has led to resistance. The company remains focused on volume growth, market share expansion, and internal efficiency programs to rebuild margins structurally.